These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4877106)

  • 41. Treponema pallidum immune adherence haemagglutination (TPIAHA) test by a micromethod.
    Arata M; Kasamatsu S; Yamaya S
    Jpn J Med Sci Biol; 1972 Aug; 25(4):287-90. PubMed ID: 4577988
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antigenic properties of certain strains of pure cultures of Treponema pallidum following complement fixation reaction with immune sera and with sera from syphilitic patients].
    ZEBNITSKAIA LV
    Vestn Venerol Dermatol; 1955; (No 4):24-7. PubMed ID: 13291722
    [No Abstract]   [Full Text] [Related]  

  • 43. [Results with the IgM-FTA-Abs and IgM-TPHA tests in the study of seropositive syphilitic sera].
    Brade V; Beuscher HU
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):521-7. PubMed ID: 6372330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of route of infection with Treponema pallidum. In vitro cellular response to treponemal antigens.
    Maret SM; Rauchbach AS; Folds JD
    Arch Pathol Lab Med; 1982 Sep; 106(9):436-9. PubMed ID: 7052010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immune adherence reaction of Treponema pallidum in the diagnosis of syphilis].
    Abidov MM; Khidyrov KhN; Sinitsyna LM; Alieva SG
    Vestn Dermatol Venerol; 1980 Feb; (2):20-3. PubMed ID: 6986723
    [No Abstract]   [Full Text] [Related]  

  • 46. Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens.
    Lukehart SA; Baker-Zander SA; Sell S
    J Immunol; 1980 Jan; 124(1):454-60. PubMed ID: 6153102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Contribution to serological differentiation of pathogenic and non-pathogenic Treponema].
    Moser L
    Zentralbl Bakteriol Orig; 1964 Jul; 193(3):375-86. PubMed ID: 5319204
    [No Abstract]   [Full Text] [Related]  

  • 48. [Causes and methods of the elimination of "nonspecific" immunofluorescence of Treponema pallidum. I. Factors responsible for nonspecific fluorescence of Treponema pallidum].
    Ruczkowska J
    Przegl Dermatol; 1982; 69(1-2):91-5. PubMed ID: 6758046
    [No Abstract]   [Full Text] [Related]  

  • 49. Antigenic characteristics of nucleic acids of cultivable treponemes.
    Király K; Jobbágy A
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Dec; 131(5):434-43. PubMed ID: 4231189
    [No Abstract]   [Full Text] [Related]  

  • 50. Syphilis serology today.
    Felman YM; Nikitas JA
    Arch Dermatol; 1980 Jan; 116(1):84-9. PubMed ID: 6986119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Syphilis complement fixation reactions with Treponema antigens. Part I. Antigen prepared from ultrasonic-treated pathogenic Treponema pallidum].
    KIRALY K
    Borgyogy Venerol Sz; 1959 Dec; 35():261-71. PubMed ID: 14409272
    [No Abstract]   [Full Text] [Related]  

  • 52. [Current trends in the Reiter protein complement fixation test].
    Nonaka K; Aoyama A; Ikeda Y; Hara Y; Toyama M
    Nihon Ika Daigaku Zasshi; 1967; 34(5):374-5. PubMed ID: 4872886
    [No Abstract]   [Full Text] [Related]  

  • 53. FTA-ABS test (using Reiter sonicate and "sorbent") in comparison with other serologic tests for syphilis.
    Tringali G; Albanese M
    Riv Ist Sieroter Ital; 1969; 44(1):51-8. PubMed ID: 4920370
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immunofluorescence anticomplement: analysis of the antibodies reacting with Treponema pallidum].
    Pillot J; Wattré P
    C R Acad Hebd Seances Acad Sci D; 1967 Nov; 265(22):1769-72. PubMed ID: 4967370
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies of the mechanism of development of agglutinability of pathogenic Treponema pallidum. 3. Changes in the activity of different antigenic components to agglutinating antibodies.
    Metzger M; Podwińska J
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):34-41. PubMed ID: 4860419
    [No Abstract]   [Full Text] [Related]  

  • 56. Humoral immune response in experimental syphilis to polypeptides of Treponema pallidum.
    Hanff PA; Bishop NH; Miller JN; Lovett MA
    J Immunol; 1983 Oct; 131(4):1973-7. PubMed ID: 6352809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The antigenic structure of Treponema pallidum, Nichols strain. I. The demonstration, nature and location of specific and shared antigens.
    Miller JN; de Bruijn JH; Bekker JH; Onvlee PC
    J Immunol; 1966 Mar; 96(3):450-6. PubMed ID: 5326762
    [No Abstract]   [Full Text] [Related]  

  • 58. [Value of the complement fixation reaction with ultrasonic-produced "Treponema pallidum" antigen for the serodiagnosis of syphilis].
    VAISMAN A; HAMELIN A
    Prophyl Sanit Morale; 1961 Oct; 33():211-25. PubMed ID: 13924227
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of the skin protection assay in experimental syphilis to assess protective immunity against a specific Treponema pallidum surface epitope.
    Blanco DR; Champion CI; Lovett MA
    FEMS Microbiol Lett; 2005 Aug; 249(1):171-5. PubMed ID: 16000244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of results of RPCF and TPHA with those of STS.
    Usui H; Nakamura S; Sawa K; Mabuchi H
    Bull Pharm Res Inst; 1968 Nov; 77():9-10. PubMed ID: 4902499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.